M. Hannouf

发表

Abstract PD6-09: Cost effectiveness of bilateral prophylactic mastectomy with and without different breast reconstruction techniques versus screening in women with high risk of breast cancer in the Canadian Province of Ontario

M. Brackstone, G. Zaric, C. Doherty, 2019, Poster Discussion Abstracts.

Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario.

M. Brackstone, G. Rodrigues, G. Zaric, 2018, Current oncology.

A review of the value of human epidermal growth factor receptor 2 (HER2)-targeted therapies in breast cancer.

S. Verma, M. Hannouf, N. Nixon, 2018, European journal of cancer.

Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma

A. Batra, D. Boyne, W. Cheung, 2022, Canadian Liver Journal.

Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov model analysis.

S. Senan, F. Lagerwaard, A. Louie, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The evolution of biosimilars in oncology, with a focus on trastuzumab.

S. Verma, M. Hannouf, N. Nixon, 2018, Current oncology.

Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada

M. Brackstone, G. Rodrigues, G. Zaric, 2015, Acta oncologica.

Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov model analysis.

S. Senan, F. Lagerwaard, A. Louie, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Letter to the Editor.

J. Lancaster, D. Muzzey, R. Kronenwett, 2019, Journal of comparative effectiveness research.

A Review of Gene Expression Profiling in Early-Stage ER+/HER2- Breast Cancer With A Focus on The PAM50 Risk of Recurrence Assay

M. Brackstone, C. Brezden-Masley, J. Raphael, 2019, EMJ Oncology.

Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer.

A. Batra, W. Cheung, M. Hannouf, 2020, Clinical colorectal cancer.

Economic Evaluation of Potential Applications of Gene Expression Profiling in Clinical Oncology

M. Hannouf, 2014 .

Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer

M. Brackstone, G. Zaric, C. McCabe, 2019, The Pharmacogenomics Journal.

Cost Effectiveness of a 21-Gene Recurrence Score Assay Versus Canadian Clinical Practice in Post-Menopausal Women with Early-Stage Estrogen or Progesterone-Receptor-Positive, Axillary Lymph-Node Positive Breast Cancer

M. Brackstone, G. Zaric, B. Xie, 2014, PharmacoEconomics.

Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer

M. Brackstone, G. Zaric, B. Xie, 2012, BMC Cancer.

Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancer.

A. Batra, G. Bigras, J. Hugh, 2021, Cancer treatment and research communications.

Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study

A. Batra, M. Hannouf, S. Lupichuk, 2020, Breast.

Cost-Effectiveness Analysis Using Registry and Administrative Data

Gregory S. Zaric, Malek B. Hannouf, G. Zaric, 2013 .

Evaluating the efficacy of current clinical practice of adjuvant chemotherapy in postmenopausal women with early-stage, estrogen or progesterone receptor-positive, one-to-three positive axillary lymph node, breast cancer.

M. Brackstone, G. Zaric, B. Xie, 2012, Current oncology.

The Clinical Significance of Occult Gastrointestinal Primary Tumours in Metastatic Cancer: A Population Retrospective Cohort Study

M. Brackstone, G. Rodrigues, G. Zaric, 2017, Cancer research and treatment : official journal of Korean Cancer Association.

1 Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clnica practice in women with early-stage estrogen-or progesterone-receptor-positive , axillary lymph-node negative breast cancer

M. Brackstone, G. Zaric, B. Xie, 2012 .

Four Cycles of Docetaxel-Cyclophosphamide versus Anthracycline-Taxane as Adjuvant Chemotherapy for HER2-Negative, Axillary Lymph Node Negative Breast Cancer: A Real-World Comparison of Alberta Patients Treated 2008–2012

A. Batra, M. Hannouf, S. Lupichuk, 2021, Current oncology.

Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer

G. Zaric, E. Winquist, J. Mocanu, 2012, PloS one.

The clinical significance of occult gynecologic primary tumours in metastatic cancer.

M. Brackstone, G. Rodrigues, G. Zaric, 2017, Current oncology.

Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary

M. Brackstone, G. Rodrigues, G. Zaric, 2016, The Pharmacogenomics Journal.

The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study

M. Brackstone, G. Rodrigues, G. Zaric, 2017, PharmacoEconomics - Open.

A Population-Based Study to Evaluate the Associations of Nodal Stage, Lymph Node Ratio and Log Odds of Positive Lymph Nodes with Survival in Patients with Small Bowel Adenocarcinoma

A. Batra, W. Cheung, S. Kong, 2022, Current oncology.

Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.

B. Yaremko, R. Malthaner, A. Louie, 2011, International journal of radiation oncology, biology, physics.

Cause-effect chains in S-LCA based on DPSIR framework using Markov healthcare model: an application to “working hours” in Canada

G. Assefa, I. Gates, M. Hannouf, 2021, The International Journal of Life Cycle Assessment.

Appraisal of Systemic Treatment Strategies in Early HER2-Positive Breast Cancer—A Literature Review

Monali Ray, J. Raphael, M. Hannouf, 2023, Cancers.

Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer

M. Brackstone, G. Zaric, C. McCabe, 2019, The Pharmacogenomics Journal.